Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-020703
Filing Date
2019-07-31
Accepted
2019-07-31 18:35:24
Documents
1
Period of Report
2019-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4388
  Complete submission text file 0000899243-19-020703.txt   5944
Mailing Address C/O RELYPSA, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
BALL KRISTINE M (Reporting) CIK: 0001266163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 19990226

Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations